Biogen and Sage Therapeutics' zuranolone has become the first oral drug to be approved by the FDA for post-partum depression (PPD), but the US regulator turned down a request for wider use in the ...
However, it has a broader label as unlike J&J's drug it is indicated for use in previously-untreated MDD. Axsome's drug was given a breakthrough designation from the FDA, reflecting the need for new ...
Major depressive disorder can be treated with different types of medications like SSRIs and SNRIs. The FDA warns that antidepressants may increase suicide risk in children and teens. Amitriptyline and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback